Condition: Mucopolysaccharidosis VII · MPS VII · MPS 7 · Sponsor: Ultragenyx Pharmaceutical Inc
The objectives of this study are to characterize MPS VII disease presentation and progression and assess long-term effectiveness and safety, including hypersensitivity reactions and immunogenicity of vestronidase alfa.
This description comes directly from the study's public registry record.
Patients Contact: Trial Recruitment · 1-888-756-8657 · trialrecruitment@ultragenyx.com
HCPs Contact: Medical Information · 1-888-756-8657 · medinfo@ultragenyx.com
Always discuss trial participation with your own doctor first.
| Children's Hospital of Orange County | Orange, California, United States | Recruiting |
| Children's National Health System | Washington D.C., District of Columbia, United States | Recruiting |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| New York University Langone Medical Center | New York, New York, United States | Terminated |
| University of Utah Medical Center | Salt Lake City, Utah, United States | Recruiting |
| Seattle Children's Hospital | Seattle, Washington, United States | Recruiting |
| Laboratorio de Neuroquimica Dr. N.A. Chamoles S.R.L. | Buenos Aires, Argentina | Recruiting |
| Hospital de Clínicas de Porto Alegre | Porto Alegre, Rio Grande do Sul, Brazil | Recruiting |
| Centre Hospitalier Universitaire La Timone | Marseille, Provence-Alpes-Côte d'Azur Region, France | Recruiting |
| Universitätsmedizin der Johannes Gutenberg-Universität Mainz | Mainz, Germany | Recruiting |
| Erasmus University Medical Center Rotterdam | Rotterdam, South Holland, Netherlands | Terminated |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03604835